Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Company News
Events
Directory
Search
Close search
Home
Company
Ori Biotech
Ori Biotech
Activities:
Pharmaceutical
X
LinkedIn
Trending Articles
Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222
Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the...
How advanced technologies are unlocking the future of drug manufacturing
As the drug production landscape changes, it opens the door to pursue hybrid opportunities that push the boundaries of technological advancement in the field, reports Jon...
Andelyn Biosciences and Grace Science, LLC partner to manufacture AAV gene therapy
The partnership will seek to maximise programme efficiency, support the ongoing clinical trial and accelerate this critical therapy to patients
Teva UK and Closed Loop Medicine partner to advance personalised medicine development
SaMD platform aims to advance personalised medicine development, improve drug efficacy and patient outcomes with specific chronic conditions
Henkel facilities receive EXCiPACT certificate as suppliers of pharmaceutical excipients
The certification means Henkel meets EXCiPACT’s guidelines for good manufacturing practice (GMP) and good distribution practice (GDP)
Upcoming event
BioProcess International Europe
9-12 April 2024 | Exhibition | RAI Amsterdam
See all
Related Content
Finance
Ori Biotech expands board of directors and scientific advisory board
Dr Annalisa Jenkins will join Ori’s board of directors, and Robert Preti will join its scientific advisory board
Finance
Ori Biotech appoints senior management roles
Stuart Milne and Kevin Gordon will join the company as CTO and Chief Data & Operating Officer respectively
Finance
Ori Biotech selected to join CGT consortium
The consortium has identified the development of process analytical technology as critical to the success of the industry
Manufacturing
Ori Biotech and Vineti collaborate on digital platform for CGTs
This partnership follows on from Ori’s $30 m Series A funding round in 2020, and Vineti’s release of its PTM Essentials solution for advanced therapy clinical trials
Finance
ATMPS and Ori Biotech collaborate on an integrated digital platform
The non-exclusive partnership will result in the integration of Ori’s proprietary CGT manufacturing platform’s data architecture with ATMPS’ Hataali secure data sharing platform
Finance
Ori Biotech completes $30m series A funding round
The Series A investor syndicate was led by the life sciences investment team at Northpond Ventures alongside Octopus Ventures
Pharmaceutical
Ori Biotech partners to test novel cell therapy manufacturing platform
Achilles Therapeutics has agreed to test Ori’s manufacturing platform in its proprietary clonal neoantigen T-cell (cNeT) therapy manufacturing process
Subscribe now